Chapter 464 Applicant Artificial Heart Clinical
More importantly, the artificial kidney of Jinlong biology has no rejection reaction, and there is no need to eat a lot of anti-rejection drugs in the later stage, although it is also necessary to supplement a little nutrient regularly, but compared with expensive anti-rejection drugs, this cost is naturally greatly reduced.
For these dead and alive patients around the world who have been suffering from kidney disease.
The success of artificial kidneys.
It's great news.
But there are also people who are very unhappy.
That's some of the companies that deal in dialysis equipment.
Even in China, there are millions of patients in need of dialysis.
Every year, the industry, including dialysis machines, is up to hundreds of billions.
Not to mention the global dialysis-related industry chain.
As long as there can be trillions.
If you switch to artificial kidneys in the future.
Then the dialysis industry will soon decline.
Therefore, there is more discussion about the ethics of artificial kidneys in society.
Especially the relevant experts of some foreign dialysis machine manufacturers.
He also expressed his opposition to artificial kidneys entering his country.
The reason is that in the opinion of these experts, people who replaced artificial kidneys.
It can't be called human anymore.
In the opinion of these experts, people should have their own characteristics.
Replacement of human organs with artificial organs.
This is a challenge to the ethical relationship of society.
The media and relevant experts of various countries are also debating this issue.
But Su Han didn't care about these things.
Originally, he also had no plans to promote artificial kidney technology abroad.
Whatever you say.
Say whatever you like.
Don't come to Huaxia when you have the ability and need a kidney replacement.
……
Now Su Han has to face the pricing problem of artificial kidney after it is introduced to the market.
Now it costs more than 600,000 to replace a traditional kidney in China.
It is equivalent to the salary of a normal person in China for more than two years.
And that's just the cost of surgery and hospitalization.
It does not include the cost of post-rejection anti-rejection.
However, the price of 600,000 yuan is already the cheapest among developed countries.
In other developed countries, it is even more expensive.
The replacement of a kidney in the Rice Federation is about 1.6 million.
According to the domestic income standard.
If Su Han set the cost of artificial kidney at one million, which is equivalent to four years of salary for ordinary people, it should be no problem.
After all, there is no rejection reaction in the later stage of artificial kidneys. Anti-rejection drugs alone can save patients a lot of money.
What's more, there is no need to take anti-rejection drugs for a long time, and it will not cause other problems in the body, such as infection problems and so on.
So this million is worth it.
But Su Han hopes that his technology can bring the benefits of medical progress to patients in China.
Think twice.
Su Han decided to set the cost of transplantation of artificial kidneys in China at 500,000 yuan.
Maintain a two-year salary.
I believe that this burden is acceptable to most people.
For some extremely poor households with subsistence allowances, but who need kidney replacement, the company can also provide subsidies.
But these subsidies need to be retrieved elsewhere.
The best targets are those who have money.
Su Han decided to tailor supporting services for the wealthy.
It's not bad money at all for these people.
The only thing that's worse is the better service.
And, of course, those foreign patients.
Because the price of kidney replacement abroad is inherently more expensive than in China.
Then it shouldn't be too expensive to be a little more expensive.
In fact, those who can come all the way from abroad for surgery should not be bad for money.
Then use these people's money to subsidize domestic patients.
There doesn't seem to be a problem either.
Although the artificial kidney of Jinlong Biotech has completed the third phase of clinical trial.
But it will be observed for a while.
……
At this time, animal experiments on artificial hearts had also been completed.
In addition to the decrease in the exercise ability of cattle and horses after surgery.
All animals are very healthy.
Chimpanzees, in particular, don't see any changes at all.
Jinlong Biotech immediately applied to the state for a clinical trial of an artificial heart.
Naturally, the relevant departments were also shocked.
The heart is arguably one of the most important organs in the human body.
The golden dragon creature can even make a heart.
That's awesome, isn't it?
In order to pass the application, Golden Dragon Biology still prepared a large number of animal experiment data.
I can't find fault with the data.
The decision was made quickly.
Golden Dragon Biology is allowed to conduct human experiments.
In fact, everyone knows that with Su Han's influence, the so-called approval is just a process.
And domestic experts in related fields also believe.
If Huaxia wants to make a breakthrough in the field of biomedicine, then it must look at Longhan Technology.
In fact, it depends on Su Han.
Because it has been proven countless times that only the industry that Su Han looks at can make progress.
Su Han can't look down on it, and it is difficult to make progress.
And the facts prove.
After entering the field of biomedicine, Longhan Technology has successively completed two major projects of artificial kidney and in vitro pregnancy.
It's a project that no one else dares to think of.
Not to mention the fact that the artificial heart has now been completed.
It seems that China's biomedical industry is about to enter the fast lane.
And the leader is Longhan Technology.
……
In the first phase of the second phase of the in vitro pregnancy experiment, the cultivation and early growth of 100 extracorporeal babies were completed.
The 100 couples who participated in the experiment were all in tears of excitement when they saw their children.
After all, they are all people who have participated in countless IVF failures.
A group of people who thought it would be impossible to have children in this life.
actually has a child of his own.
It's like a dream for these people.
In subsequent experiments.
These people also have to participate in in extracorporeal prenatal education experiments.
……
May.
Just when the state approved the first phase of clinical trials of Jinlong Bio's artificial heart.
Artificial kidneys were put on the market.
Although the marketing trial is not really a listing.
But for Golden Dragon Biotech and the hospitals that perform the relevant surgeries.
It is already possible to make money for a fee.
At this time, artificial kidneys were already known to everyone among patients with kidney disease.
A large number of patients in China who urgently need kidney replacement have come to the hospital of Longhan Technology in Beijing to apply for kidney replacement.
There will be 10,000 places in this marketing trial.
Sixty percent of this will be allocated to general patients in the country.
Forty percent will be allocated to VIP patients and patients abroad.
For domestic patients, the replacement of a kidney is close to 500,000, which is barely affordable.
VIP patients are rich people, and it is acceptable to be a little more expensive.
But for patients abroad, a kidney exchange of 1.5 million is not so kind.
After all, surgery in Huaxia cannot go through medical insurance.
One and a half million is all personally responsible.
Naturally, some foreign patients are a little Alexander.
However, these are not within Su Han's consideration.
Surgery abroad is inherently expensive.
That's all there is to it anyway.
Love to do it or not.
Although the price is a little higher, it only takes a little hesitation for a moment to sell out the places.